Market research
3MT.F Magenta Therapeutics, Inc
F EUR Not available
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 29M
- P/E ratio
- Not available
- Analyst target
- 15.71
- Dividend yield
- 0.0%
- Beta
- 2.12
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Not available
- Industry
- Not available
- ISIN
- US55910K1088
- Market cap
- 29M
- P/E ratio
- Not available
- Analyst target
- 15.71
- Dividend yield
- 0.0%
- Beta
- 2.12
About
About Magenta Therapeutics, Inc
Dianthus Therapeutics, Inc. operates as a clinical-stage biotechnology company that designs and delivers novel monoclonal antibodies. It develops monoclonal antibodies and complement therapeutics to deliver transformative medicines for patients with rare diseases. Dianthus Therapeutics, Inc. was incorporated in 2019 and is based in Waltham, Massachusetts, with an additional office in New York, New York.
Visit company websiteCommunity
Investor discussion
0 comments
Sign in to join the 3MT.F discussion.
No comments yet
Start a focused discussion about 3MT.F.